logo-loader

Achillion Pharmaceuticals, Inc.

Receive alerts
Market:
NASDAQ
Market Cap:
$947.02 m
Price
6.76 USD
Change
10.28%
52 weeks high
7.01
52 weeks low
2.07

In brief

Achillion Pharmaceuticals, Inc. (Achillion) is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. Within the anti-infective market, the Company focuses on the development of antivirals for the treatment of chronic hepatitis C and the development of antibacterials for the treatment of resistant bacterial infections.